Ocular Safety of Intravitreal Engineered Humanized Anti-VEGF Nanobody and Its Efficacy in the Attenuation of Choroidal Neovascularization and Associated Subretinal Fibrosis

Current treatments for choroidal neovascularization (CNV) and its associated subretinal fibrosis (SRF), major causes of vision loss, are limited by the need for frequent intravitreal injections and the emergence of drug resistance. This study evaluated the safety and efficacy of the intravitreal adm...

Descripción completa

Detalles Bibliográficos

Autores principales:	Mir Salar Kazemi, Mozhgan Rezaei Kanavi, Fatemeh Kazemi-Lomedasht, Reza Ahangari Cohan, Golnoosh Mahjoobi, Sare Safi, Sadra Ashrafi, Hamid Ahmadieh, Alireza Shoari, Mahdi Behdani
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2026-05-01
Colección:	Biomolecules
Materias:	choroidal neovascularization subretinal fibrosis nanobody intravitreal injection angiogenesis inflammation
Acceso en línea:	https://www.mdpi.com/2218-273X/16/6/772
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!